IMPORTANT! Reports of Adult RSV Vaccine Products Improperly Given to Infants

Minnesota Department of Health sent this bulletin at 11/21/2023 09:38 AM CST

Reports of adult RSV vaccine products improperly given to infants

November 21, 2023

Do not inadvertently give RSV vaccines (Abrysvo or Arexvy) to infants. CDC has received several reports of this happening when the infant should have received the RSV monoclonal antibody (nirsevimab).

Vaccine providers who carry both nirsevimab (for use in infants and young children) and RSV vaccines (for use in older adults and pregnant people) should be especially diligent in following vaccine administration safety procedures to prevent errors.To minimize risk of errors, store RSV vaccine and monoclonal antibodies in their original packaging on different shelves and clearly label them. Also ensure the seven rights of vaccine administration have been performed:

Right patient
Right time
Right vaccine and diluent
Right dosage
Right route, needle length, and technique
Right site
Right documentation

In the event RSV vaccine (Abrysvo or Arexvy) was administered to an infant:

Inform the provider and the parent/guardian of the error.
Email CDC nipinfo@cdc.gov (and "Cc" MDH health.vaccineSME@state.mn.us) for guidance on next steps.

Promptly report the error to the Vaccine Adverse Event Reporting System (VAERS).

For more information, contact health.vaccineSME@state.mn.us.